These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
249 related articles for article (PubMed ID: 8972026)
1. Distinct patterns of urokinase receptor (uPAR) expression by leukemic cells and peripheral blood cells. Jardí M; Inglés-Esteve J; Burgal M; Azqueta C; Velasco F; López-Pedrera C; Miles LA; Félez J Thromb Haemost; 1996 Dec; 76(6):1009-19. PubMed ID: 8972026 [TBL] [Abstract][Full Text] [Related]
2. Structure, function and expression on blood and bone marrow cells of the urokinase-type plasminogen activator receptor, uPAR. Plesner T; Behrendt N; Ploug M Stem Cells; 1997; 15(6):398-408. PubMed ID: 9402652 [TBL] [Abstract][Full Text] [Related]
3. Enhanced expression of urokinase receptor induced through the tissue factor-factor VIIa pathway in human pancreatic cancer. Taniguchi T; Kakkar AK; Tuddenham EG; Williamson RC; Lemoine NR Cancer Res; 1998 Oct; 58(19):4461-7. PubMed ID: 9766679 [TBL] [Abstract][Full Text] [Related]
4. EGF-stimulated migration in ovarian cancer cells is associated with decreased internalization, increased surface expression, and increased shedding of the urokinase plasminogen activator receptor. Henic E; Sixt M; Hansson S; Høyer-Hansen G; Casslén B Gynecol Oncol; 2006 Apr; 101(1):28-39. PubMed ID: 16263158 [TBL] [Abstract][Full Text] [Related]
5. Tissue factor (TF) and urokinase plasminogen activator receptor (uPAR) and bleeding complications in leukemic patients. López-Pedrera C; Jardí M; del Mar Malagón M; Inglés-Esteve J; Dorado G; Torres A; Félez J; Velasco F Thromb Haemost; 1997 Jan; 77(1):62-70. PubMed ID: 9031451 [TBL] [Abstract][Full Text] [Related]
6. Interleukin-1alpha enhances the aggressive behavior of pancreatic cancer cells by regulating the alpha6beta1-integrin and urokinase plasminogen activator receptor expression. Sawai H; Okada Y; Funahashi H; Matsuo Y; Takahashi H; Takeyama H; Manabe T BMC Cell Biol; 2006 Feb; 7():8. PubMed ID: 16504015 [TBL] [Abstract][Full Text] [Related]
7. The urokinase-receptor (CD87) is expressed in cells of the megakaryoblastic lineage. Wohn KD; Kanse SM; Deutsch V; Schmidt T; Eldor A; Preissner KT Thromb Haemost; 1997 Mar; 77(3):540-7. PubMed ID: 9066008 [TBL] [Abstract][Full Text] [Related]
8. Mitogenic signaling of urokinase receptor-deficient kidney fibroblasts: actions of an alternative urokinase receptor and LDL receptor-related protein. Zhang G; Cai X; López-Guisa JM; Collins SJ; Eddy AA J Am Soc Nephrol; 2004 Aug; 15(8):2090-102. PubMed ID: 15284295 [TBL] [Abstract][Full Text] [Related]
9. In situ gene expression of urokinase-type plasminogen activator and its receptor in transitional cell carcinoma of the human bladder. Bhuvarahamurthy V; Schroeder J; Denkert C; Kristiansen G; Schnorr D; Loening SA; Jung K; Staack A Oncol Rep; 2004 Oct; 12(4):909-13. PubMed ID: 15375521 [TBL] [Abstract][Full Text] [Related]
10. Expression and function of the urokinase type plasminogen activator during mouse hemochorial placental development. Teesalu T; Blasi F; Talarico D Dev Dyn; 1998 Sep; 213(1):27-38. PubMed ID: 9733098 [TBL] [Abstract][Full Text] [Related]
11. Macrophage inhibitory cytokine-1 induces the invasiveness of gastric cancer cells by up-regulating the urokinase-type plasminogen activator system. Lee DH; Yang Y; Lee SJ; Kim KY; Koo TH; Shin SM; Song KS; Lee YH; Kim YJ; Lee JJ; Choi I; Lee JH Cancer Res; 2003 Aug; 63(15):4648-55. PubMed ID: 12907645 [TBL] [Abstract][Full Text] [Related]
12. Urokinase plasminogen activator and urokinase plasminogen activator receptor mediate human stem cell tropism to malignant solid tumors. Gutova M; Najbauer J; Frank RT; Kendall SE; Gevorgyan A; Metz MZ; Guevorkian M; Edmiston M; Zhao D; Glackin CA; Kim SU; Aboody KS Stem Cells; 2008 Jun; 26(6):1406-13. PubMed ID: 18403751 [TBL] [Abstract][Full Text] [Related]
13. Soluble urokinase receptor levels correlate with number of circulating tumor cells in acute myeloid leukemia and decrease rapidly during chemotherapy. Mustjoki S; Sidenius N; Sier CF; Blasi F; Elonen E; Alitalo R; Vaheri A Cancer Res; 2000 Dec; 60(24):7126-32. PubMed ID: 11156421 [TBL] [Abstract][Full Text] [Related]
14. Epitope-mapped monoclonal antibodies as tools for functional and morphological analyses of the human urokinase receptor in tumor tissue. Luther T; Magdolen V; Albrecht S; Kasper M; Riemer C; Kessler H; Graeff H; Müller M; Schmitt M Am J Pathol; 1997 Apr; 150(4):1231-44. PubMed ID: 9094980 [TBL] [Abstract][Full Text] [Related]
15. Differential gene expression of urokinase-type plasminogen activator and its receptor in human renal cell carcinoma. Bhuvarahamurthy V; Schroeder J; Kristiansen G; Roigas J; Denkert C; Johannsen M; Lein M; Loening SA; Schnorr D; Jung K; Staack A Oncol Rep; 2005 Sep; 14(3):777-82. PubMed ID: 16077991 [TBL] [Abstract][Full Text] [Related]
16. A urokinase receptor mRNA binding protein-mRNA interaction regulates receptor expression and function in human pleural mesothelioma cells. Shetty S; Idell S Arch Biochem Biophys; 1998 Aug; 356(2):265-79. PubMed ID: 9705217 [TBL] [Abstract][Full Text] [Related]
17. Expression and release of plasminogen activators, their inhibitors and receptor by human tumor cell lines. Buø L; Bjørnland K; Karlsrud TS; Kvale D; Kjønniksen I; Fodstad O; Brandtzaeg P; Johansen HT; Aasen AO Anticancer Res; 1994; 14(6B):2445-51. PubMed ID: 7872665 [TBL] [Abstract][Full Text] [Related]
18. Involvement of the [uPAR:uPA:PAI-1:LRP] complex in human myogenic cell motility. Chazaud B; Bonavaud S; Plonquet A; Pouchelet M; Gherardi RK; Barlovatz-Meimon G Exp Cell Res; 2000 Aug; 258(2):237-44. PubMed ID: 10896774 [TBL] [Abstract][Full Text] [Related]
19. Receptor-mediated regulation of plasminogen activator function: plasminogen activation by two directly membrane-anchored forms of urokinase. Vines DJ; Lee SW; Dichek DA; Ellis V J Pept Sci; 2000 Sep; 6(9):432-9. PubMed ID: 11016879 [TBL] [Abstract][Full Text] [Related]
20. Localization and significance of urokinase plasminogen activator and its receptor in placental tissue from intrauterine, ectopic and molar pregnancies. Floridon C; Nielsen O; Holund B; Sunde L; Westergaard JG; Thomsen SG; Teisner B Placenta; 1999 Nov; 20(8):711-21. PubMed ID: 10527826 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]